Implementation of a next-generation sequencing and PD-L1 immunohistochemistry reflex testing protocol for non–small cell lung cancers improves turnaround time
Reduction in median TAT from procedure to NGS sign-out was statistically significant after implementation of reflex biomarker testing in NSCLC samples.
Authors
- David Shersher (ORCID: https://orcid.org/0000-0002-3421-3763)
- Kathryn C. Behling (ORCID: https://orcid.org/0000-0002-6188-2452)
- C. Kendall Major (ORCID: https://orcid.org/0000-0003-1507-331X)
- Polina Khrizman
- Tina Bocker Edmonston (ORCID: https://orcid.org/0000-0001-7877-4637)
- Chiara Jean Cocelli
Institutions
- Cooper University Hospital (US)
- Cooper Medical School of Rowan University (US)
- Cooper University Health Care (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1093/ajcp/aqaf107
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00